medoja

Medoja — Header & Navigation
Hydroxyapatite Nutraceutical Grade | Calcium | Medoja
Nutraceutical Grade Bone Health Calcium Intake Mineral Absorption Joint Health Sports Nutrition Skeletal Integrity Pipeline B2B Nutraceutical Grade Bone Health Calcium Intake Mineral Absorption Joint Health Sports Nutrition Skeletal Integrity Pipeline B2B
Overview

Medoja is developing nutraceutical-grade Hydroxyapatite (HA) as a potent supplement Ingredient to help strengthen and maintain healthy bones.

By boosting calcium intake and supporting effective mineral absorption. The Formulation Based with our HAp- aim to reduce the risk of osteoporosis and provide essential nutritional support. These products also promote joint health, preserving function and mobility for individuals leading active lifestyles.

Furthermore, our hydroxyapatite is particularly well-suited for sports nutrition formulations, enhancing bone density and performance in athletes seeking a competitive edge.

Medoja Bio Pvt. Ltd.
HA · Nutraceutical
Nutraceutical-Grade Hydroxyapatite by Medoja Bio
Grade
Nutraceutical
Use
B2B
Stage
Pipeline
01 — Bone Health
Strength & Mineral Absorption

HA for Stronger Bones & Better Mineral Uptake

Boosts Calcium Intake

Nutraceutical-grade HA Ingredient calcium intake through a bone-identical mineral source — calcium delivered in its natural biological form. The aim is to provide essential nutritional support for skeletal health, beyond what isolated calcium salts can offer.

Supports Effective Mineral Absorption

Our HA-based formulations support effective mineral absorption — the close resemblance of hydroxyapatite to natural bone mineral allows it to integrate seamlessly into daily regimens. The goal is to reduce the risk of osteoporosis and contribute to more robust bones over time.

Promotes Joint Health & Mobility

The products developed with our HA also promote joint health, preserving function and mobility for individuals leading active lifestyles. The synergy of minerals contributes to better overall health, ensuring that our nutraceutical-grade HA delivers benefits beyond standard calcium supplements.

02 — Applications

HA for Everyday Wellness & Sports Nutrition

Medoja Nutraceutical-Grade Hydroxyapatite for daily wellness and sports nutrition
Daily Wellness · Joint Health · Sports Nutrition

Whether used for everyday wellness or high-intensity athletic pursuits, our hydroxyapatite-based formulations offer a reliable path to maintaining bone strength and optimizing physical performance.

For daily regimens, our nutraceutical-grade HA provides essential nutritional support — boosting calcium intake, supporting effective mineral absorption, and promoting joint function and mobility. It is designed for individuals leading active lifestyles who want a reliable foundation for long-term skeletal health.

For sports nutrition formulations, our HAp Ingredient is particularly well-suited to enhance bone density and performance in athletes seeking a competitive edge. Its close resemblance to natural bone mineral allows seamless integration into performance-focused supplements.

A reliable foundation for daily skeletal support

Nutraceutical-grade HA boosts calcium intake and supports mineral absorption — reducing the risk of osteoporosis and preserving joint function and mobility over the long term.

Enhanced bone density & athletic performance

Particularly well-suited for developing sports nutrition formulations — HA enhances bone density and performance in athletes seeking a competitive edge through high-intensity athletic pursuits.

03 — Development
R&D Pipeline & Formulation Focus

Engineering the Next Generation of Nutraceutical HA

Medoja's HA is positioned in our B2B development pipeline, designed for partners formulating bone-health, joint, and sports-nutrition supplements. Three focus areas are shaping our nutraceutical-grade HA programme:

Focus Area No. 01

Bone-Identical MineralCa₁₀(PO₄)₆(OH)₂

Leveraging the close resemblance of HA to natural bone mineral so it integrates seamlessly into daily regimens — for benefits beyond standard calcium supplements.

Key Attribute
Biomimetic Match
Focus Area No. 02

Mineral AbsorptionCalcium & Phosphate Synergy

Formulations engineered to boost calcium intake and support effective mineral absorption — aiming to reduce the risk of osteoporosis and provide essential nutritional support.

Key Attribute
Synergistic Uptake
Focus Area No. 03

Sports Nutrition GradePerformance & Bone Density

Particularly well-suited for sports nutrition — enhancing bone density and performance in athletes seeking a competitive edge during high-intensity athletic pursuits.

Key Attribute
Active Lifestyles

Our nutraceutical-grade HA delivers benefits beyond standard calcium supplements, contributing to more robust bones and better overall health. Medoja Bio Pvt. Ltd. partners with supplement brands and formulators developing the next generation of bone-health and sports-nutrition products.

04 — Outlook
What's Next

The Future of HA in Bone-Health Nutraceuticals

Nutraceutical-grade hydroxyapatite is poised to become a foundational ingredient for the next generation of bone-health and sports-nutrition supplements — delivering benefits beyond standard calcium supplements through a biomimetic, bone-identical mineral source.

01
Daily Wellness

Mainstream Bone-Health Formulations

HA-based formulations integrated into daily regimens for adults seeking to reduce the risk of osteoporosis and maintain joint function.

02
Athletic Edge

Performance Sports Nutrition

HA blends tailored for athletes — enhancing bone density and performance for those pursuing a competitive edge in high-intensity sport.

03
Active Lifestyles

Synergistic Mineral Stacks

Combined formulations leveraging the synergy of minerals for more robust bones, better overall health, and improved skeletal integrity.

With nutraceutical-grade HA delivering benefits beyond standard calcium supplements, the next generation of bone-health products will be more biomimetic, more effective, and better matched to active lifestyles. As part of this innovation, Sustainable Biomaterials are gaining attention for their role in safer, plant-derived nutritional support.

05 — FAQs
Common Questions

Frequently Asked Questions

01 What makes nutraceutical-grade Hydroxyapatite different from a standard calcium supplement?

Standard calcium supplements deliver calcium in isolation. Medoja's nutraceutical-grade HA is a complete bone mineral — chemically identical to the calcium-phosphate compound that already exists in human bone (Ca₁₀(PO₄)₆(OH)₂). This close resemblance to natural bone mineral supports effective absorption and delivers benefits beyond standard calcium supplements — contributing to more robust bones and better overall health.

02 Is this a finished consumer product or a B2B ingredient?

Hydroxyapatite (Nutraceutical) sits in Medoja's B2B pipeline — it is being developed as a high-quality bone-mineral ingredient for formulators and supplement brands building bone-health, joint-health, and sports-nutrition products. We supply to manufacturers; the consumer-facing product is created by our partners. Custom specifications can be discussed at the enquiry stage.

03 How does HA help reduce the risk of osteoporosis?

By boosting calcium intake and supporting effective mineral absorption, our HA-based formulations aim to reduce the risk of osteoporosis and provide essential nutritional support. The minerals integrate seamlessly into daily regimens, contributing to improved skeletal integrity and more robust bones over time — addressing the structural foundation that osteoporosis directly compromises.

04 When will the product be available and how can I get involved?

The product is currently in our development pipeline. We welcome conversations with formulators, supplement brands, and sports-nutrition partners interested in early collaboration, samples, or specifications. The fastest path is to register interest via our contact page — our team will follow up with current development status, partnership options, and a Certificate of Analysis once formulations are released.